Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22343511 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV
Condition: HBV
Intervention: Drug: Telbivudine
2 Completed Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels
Conditions: Chronic Hepatitis B;   Pregnancy Complications;   High Viral Load;   Elevated Alanine Aminotransferase Levels
Intervention: Drug: Telbivudine treatment

Indicates status has not been verified in more than two years